Literature DB >> 21459489

[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].

José María Aguado1, Isabel Ruiz-Camps, Patricia Muñoz, José Mensa, Benito Almirante, Lourdes Vázquez, Montserrat Rovira, Pilar Martín-Dávila, Asunción Moreno, Francisco Alvarez-Lerma, Cristóbal León, Luis Madero, Jesús Ruiz-Contreras, Jesús Fortún, Manuel Cuenca-Estrella.   

Abstract

These guidelines are an update of the recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) that were issued in 2004 (Enferm Infecc Microbiol Clin. 2004, 22:32-9) on the treatment of Invasive Candidiasis and infections produced by other yeasts. This 2010 update includes a comprehensive review of the new drugs that have appeared in recent years, as well as the levels of evidence for recommending them. These guidelines have been developed following the rules of the SEIMC by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. It provides a series of general recommendations regarding the management of invasive candidiasis and other yeast infections, as well as specific guidelines for prophylaxis and treatment, which have been divided into four sections: oncology-haematology, solid organ transplantation recipients, critical patients, and paediatric patients.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21459489     DOI: 10.1016/j.eimc.2011.01.008

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  8 in total

Review 1.  Antifungal clinical trials and guidelines: what we know and do not know.

Authors:  Peter G Pappas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin.

Authors:  María Teresa Durán-Valle; Sara Gago; Alicia Gómez-López; Manuel Cuenca-Estrella; Leticia Jiménez Díez-Canseco; José Luis Gómez-Garcés; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

3.  Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.

Authors:  Daniel Brustolin Ludwig; Luciana Erzinger Alves de Camargo; Najeh Maissar Khalil; Marcos Ereno Auler; Rubiana Mara Mainardes
Journal:  Mycopathologia       Date:  2018-03-01       Impact factor: 2.574

4.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

5.  Candidemia in Colombia

Authors:  Jorge Alberto Cortés; José Franklin Ruiz; Lizeth Natalia Melgarejo-Moreno; Elkin V Lemos
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

6.  [Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant].

Authors:  Asunción Moreno Camacho; Isabel Ruiz Camps
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-06-18       Impact factor: 1.731

7.  Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.

Authors:  S Grau; J C Pozo; E Romá; M Salavert; J A Barrueta; C Peral; I Rodriguez; D Rubio-Rodríguez; C Rubio-Terrés
Journal:  Clinicoecon Outcomes Res       Date:  2015-10-13

Review 8.  Clinical practice update of antifungal prophylaxis in immunocompromised children.

Authors:  J T Ramos; C A Romero; S Belda; F J Candel; B Carazo Gallego; A Fernández-Polo; L Ferreras Antolín; C Garrido Colino; M L Navarro; O Nef; P Olbright; E Rincón-López; J Ruiz Contreras; P Soler-Palacín
Journal:  Rev Esp Quimioter       Date:  2019-09-11       Impact factor: 1.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.